- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 72
Smart Protection collects series B funds
Telefónica Tech Ventures and Bankinter invested in an $11.9m round that will drive international growth for the anti-piracy software producer.
Nov 19, 2020Amiro rakes in series B funding
The Xiaomi-backed beauty device provider picked up $15.2m from investors including Fortune Capital after reporting over $8m of sales on Chinese Single's Day.
Nov 19, 2020SendCloud collects series B funding
Axa Venture Partners led a $14.9m round for the e-commerce fulfilment platform developer, which counts SanomaVentures as an earlier backer.
Nov 19, 2020Upfront Healthcare gets series B backing
The $11.5m Echo Health Ventures-backed round more than doubled the healthcare navigation app developer's overall funding.
Nov 18, 2020Hacarus hacks series B funding
MTG Ventures and Ohara Pharmaceutical backed the second close of the medical data modelling technology developer’s latest round, which stands at $12.4m.
Nov 17, 2020Unilabo unites corporates for series B round
Japan Post Capital co-led a $13.8m round for the B2B subcontracting service that included Hakuhodo DY Ventures, Mitsubishi UFJ Capital, SBI Investment and UB Ventures.
Nov 17, 2020Bridge Medicines crosses $10m
Existing backers Takeda, Deerfield and Bay City Capital have provided $10m to help progress research from multiple institutions.
Nov 17, 2020Springtide sparks series A surge
The child developmental therapy provider closed an $18.1m round co-led by Optum Ventures, which will take a board seat at the company.
Nov 17, 2020Corporate venturing deal net: 9-13 November 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Nov 13, 2020Kira comes out of stealth with $46m
Sinopharm Capital and the WuXi AppTec-backed 6 Dimensions Capital are among the investors in the inflammatory and autoimmune disease drug developer.
Nov 13, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


